Trials / Unknown
UnknownNCT04631575
An Investigational Study of SHR6390 in Participants With Mild to Moderate Liver Impairment and Healthy Participants
A Single Dose, Open-label, Parallel Controlled Pharmacokinetic Study of SHR6390 in Participants With Mild to Moderate Liver Impairment and Healthy Participants
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate SHR6390 in participants with different levels of liver function
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR6390 | SHR6390, PO,single-dose |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-03-01
- Completion
- 2021-03-01
- First posted
- 2020-11-17
- Last updated
- 2020-11-17
Source: ClinicalTrials.gov record NCT04631575. Inclusion in this directory is not an endorsement.